Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer.

Edelman R, Assaraf YG, Slavkin A, Dolev T, Shahar T, Livney YD.

Pharmaceutics. 2019 May 5;11(5). pii: E216. doi: 10.3390/pharmaceutics11050216.

2.

Unraveling the transcriptional regulation of TWIST1 in limb development.

Hirsch N, Eshel R, Bar Yaacov R, Shahar T, Shmulevich F, Dahan I, Levaot N, Kaplan T, Lupiáñez DG, Birnbaum RY.

PLoS Genet. 2018 Oct 29;14(10):e1007738. doi: 10.1371/journal.pgen.1007738. eCollection 2018 Oct.

3.

Neurocognitive evaluation of brain metastases patients treated with post-resection stereotactic radiosurgery: a prospective single arm clinical trial.

Berger A, Strauss I, Ben Moshe S, Corn BW, Limon D, Shtraus N, Shahar T, Kanner AA.

J Neurooncol. 2018 Nov;140(2):307-315. doi: 10.1007/s11060-018-2954-x. Epub 2018 Aug 4.

PMID:
30078070
4.

Androgen receptor: a potential therapeutic target for glioblastoma.

Zalcman N, Canello T, Ovadia H, Charbit H, Zelikovitch B, Mordechai A, Fellig Y, Rabani S, Shahar T, Lossos A, Lavon I.

Oncotarget. 2018 Apr 13;9(28):19980-19993. doi: 10.18632/oncotarget.25007. eCollection 2018 Apr 13.

5.

The EU-Emotion Voice Database.

Lassalle A, Pigat D, O'Reilly H, Berggen S, Fridenson-Hayo S, Tal S, Elfström S, Råde A, Golan O, Bölte S, Baron-Cohen S, Lundqvist D.

Behav Res Methods. 2019 Apr;51(2):493-506. doi: 10.3758/s13428-018-1048-1.

6.

MRI radiomics analysis of molecular alterations in low-grade gliomas.

Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T.

Int J Comput Assist Radiol Surg. 2018 Apr;13(4):563-571. doi: 10.1007/s11548-017-1691-5. Epub 2017 Dec 21.

PMID:
29270916
7.

Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.

Lang FM, Hossain A, Gumin J, Momin EN, Shimizu Y, Ledbetter D, Shahar T, Yamashita S, Parker Kerrigan B, Fueyo J, Sawaya R, Lang FF.

Neuro Oncol. 2018 Feb 19;20(3):380-390. doi: 10.1093/neuonc/nox152.

8.

Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.

Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF.

Cancer Res. 2017 Nov 1;77(21):5808-5819. doi: 10.1158/0008-5472.CAN-16-2524. Epub 2017 Aug 30.

9.

Elaborate mapping of the posterior visual pathway in awake craniotomy.

Shahar T, Korn A, Barkay G, Biron T, Hadanny A, Gazit T, Nossek E, Ekstein M, Kesler A, Ram Z.

J Neurosurg. 2018 May;128(5):1503-1511. doi: 10.3171/2017.2.JNS162757. Epub 2017 Aug 25.

PMID:
28841121
10.

Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.

Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF.

Neuro Oncol. 2017 May 1;19(5):660-668. doi: 10.1093/neuonc/now239.

11.

Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.

Edelman R, Assaraf YG, Levitzky I, Shahar T, Livney YD.

Oncotarget. 2017 Apr 11;8(15):24337-24353. doi: 10.18632/oncotarget.15363.

12.

Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literature.

Gelerstein E, Berger A, Jonas-Kimchi T, Strauss I, Kanner AA, Blumenthal DT, Gottfried M, Margalit N, Ram Z, Shahar T.

J Clin Neurosci. 2017 Mar;37:51-53. doi: 10.1016/j.jocn.2016.11.011. Epub 2017 Jan 12. Review.

PMID:
28089420
13.

Basic and complex emotion recognition in children with autism: cross-cultural findings.

Fridenson-Hayo S, Berggren S, Lassalle A, Tal S, Pigat D, Bölte S, Baron-Cohen S, Golan O.

Mol Autism. 2016 Dec 19;7:52. doi: 10.1186/s13229-016-0113-9. eCollection 2016.

14.

Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Shahar T, Granit A, Zrihan D, Canello T, Charbit H, Einstein O, Rozovski U, Elgavish S, Ram Z, Siegal T, Lavon I.

J Neurooncol. 2016 Dec;130(3):413-422. Epub 2016 Aug 29.

PMID:
27573219
15.

A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells.

Volovitz I, Shapira N, Ezer H, Gafni A, Lustgarten M, Alter T, Ben-Horin I, Barzilai O, Shahar T, Kanner A, Fried I, Veshchev I, Grossman R, Ram Z.

BMC Neurosci. 2016 Jun 1;17(1):30. doi: 10.1186/s12868-016-0262-y.

16.

Craniectomy Versus Craniotomy for Posterior Fossa Metastases: Complication Profile.

Hadanny A, Rozovski U, Nossek E, Shapira Y, Strauss I, Kanner AA, Sitt R, Ram Z, Shahar T.

World Neurosurg. 2016 May;89:193-8. doi: 10.1016/j.wneu.2016.01.076. Epub 2016 Feb 4.

PMID:
26852713
17.

Herpes Simplex Type 2 Encephalitis After Craniotomy: Case Report and Literature Review.

Berger A, Shahar T, Margalit N.

World Neurosurg. 2016 Apr;88:691.e9-691.e12. doi: 10.1016/j.wneu.2015.11.101. Epub 2015 Dec 25. Review.

PMID:
26724620
18.

Embodied simulation in exposure-based therapies for posttraumatic stress disorder-a possible integration of cognitive behavioral theories, neuroscience, and psychoanalysis.

Peri T, Gofman M, Tal S, Tuval-Mashiach R.

Eur J Psychotraumatol. 2015 Nov 20;6:29301. doi: 10.3402/ejpt.v6.29301. eCollection 2015.

19.

The EU-Emotion Stimulus Set: A validation study.

O'Reilly H, Pigat D, Fridenson S, Berggren S, Tal S, Golan O, Bölte S, Baron-Cohen S, Lundqvist D.

Behav Res Methods. 2016 Jun;48(2):567-76. doi: 10.3758/s13428-015-0601-4.

PMID:
26424443
20.

Patterns of Failure after Stereotactic Radiosurgery of the Resection Cavity Following Surgical Removal of Brain Metastases.

Strauss I, Corn BW, Krishna V, Shahar T, Matceyevsky D, Gez E, Shtraus N, Ram Z, Kanner AA.

World Neurosurg. 2015 Dec;84(6):1825-31. doi: 10.1016/j.wneu.2015.07.073. Epub 2015 Aug 14.

PMID:
26283490

Supplemental Content

Loading ...
Support Center